This Request for Proposals (RFP) invites organizations to submit proposals for quality improvement initiatives focused on promoting intramuscular vaccination methods for children among healthcare professionals in Japan. The goal is to support projects that enhance the skills, knowledge, and adoption of intramuscular vaccination techniques in pediatric settings.

Geographic Scope and Project Focus

The geographic scope of this RFP is limited to Japan. Projects must directly address the promotion of intramuscular vaccination methods for children among healthcare professionals involved in pediatric vaccination services.

Eligible projects include those aimed at improving skills and behavioral changes, establishing intramuscular vaccination methods, and eliminating aversion to these methods. The focus is on practical application and integration of intramuscular vaccination techniques in clinical practice.

System-based changes and educational efforts are encouraged, with priority given to projects demonstrating a direct impact on patient care. Projects should be evidence-based and follow generally accepted scientific principles.

Key Dates and Funding Details

The application submission deadline is June 30, 2025, with an extended due date of July 14, 2025. Notification of decisions is anticipated by September 14, 2025, and the anticipated project start date is October 1, 2025.

Individual projects may request up to 5,000,000 JPY. The project execution period is from October 1, 2025, to September 30, 2027 (2 years).

The amount of funding awarded will depend on the expert review panel's evaluation of the proposal and associated costs. The approved amount will be clearly stated in the approval notification.

Eligibility Criteria

Only organizations are eligible to receive grants; individuals or medical practice groups are not eligible. Eligible organizations may include medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions; professional associations; and government agencies.

Collaborations within and between institutions/organizations/associations are encouraged, provided all partners have a relevant role and the requesting organization has a key role in the project. For projects offering continuing education credit, the requesting organization must be accredited.

• Medical, dental, nursing, allied health, and/or pharmacy professional schools

• Healthcare institutions (both large and small)

• Professional associations

• Government agencies

• Other entities with a mission related to healthcare improvement

Specific Areas of Interest

This RFP seeks to support projects that establish a system enabling healthcare professionals to safely and appropriately practice and promote intramuscular vaccination methods for children. Projects should focus on improving skills, knowledge, and confidence in administering intramuscular injections.

Priority will be given to projects that utilize system-based changes and demonstrate a direct impact on patient care. Educational efforts for grantees and patients are appropriate components, but projects with overt descriptions of system changes will be highly prioritized.

Clinical research projects and projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered. The focus should be on quality improvement and implementation of best practices.

Submission Requirements and Process

Applications must be submitted through the online portal at www.cybergrants.com/pfizer/QI. First-time users should create a password to access the system.

In the application, select the Competitive Grant Program Name: “2025 VAC JP Promote Intramuscular Vaccination Methods for Children QI” and the Primary Area of Interest: VAV – General/Non-specific/Other - QI. Complete all required sections of the online application and upload your project proposal in the Full Proposal Submission field.

Applications submitted after the due date will not be reviewed. Questions regarding this RFP should be directed in writing to the Grant Officer, Akihiro Kamina (meg.japan@pfizer.com), with the subject line “Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for Children.”